Tumores odontogénicos malignos prevalentes en América Latina: una guía clínica

Abstract

Seventy six percent of the malignant odontogenic tumors diagnosed in Latin America are carcino- mas, with ameloblastic carcinoma and primary intraosseous carcinoma being the most prevalent. Based on this background, this guide develops under the Agree II guideline, the definition, diag- nostic criteria, prognosis and treatment with reference and counter-reference criteria of these two pathological entities with the highest diagnosis in the region. The objective is to provide elements that facilitate the presumptive diagnosis of this type and nature of odontogenic tumors for the den- tist, and on the other hand, to guide clinicians and head and neck surgeons in making therapeutic decisions, since until now, there is no standardized treatment for these two carcinomas.